1,459
Views
1
CrossRef citations to date
0
Altmetric
Research Paper

The crystallin alpha B (HSPB5)-tripartite motif containing 33 (TRIM33) axis mediates myocardial fibrosis induced by angiotensinogen II through transforming growth factor-β (TGF-β1)-Smad3/4 signaling

, , , , , , , & show all
Pages 8836-8849 | Received 23 Dec 2021, Accepted 14 Mar 2022, Published online: 25 Mar 2022

References

  • Bekfani T, Fudim M, Cleland JGF, et al. A current and future outlook on upcoming technologies in remote monitoring of patients with heart failure. Eur J Heart Fail. 2021;23(1):175–185.
  • Kimball TH, Vondriska TM. Metabolism, epigenetics, and causal inference in heart failure. Trends Endocrinol Metab. 2020;31(3):181–191.
  • Butler J, Packer M, Greene SJ, et al. Heart failure end points in cardiovascular outcome trials of sodium glucose cotransporter 2 inhibitors in patients with type 2 diabetes mellitus: a critical evaluation of clinical and regulatory issues. Circulation. 2019;140(25):2108–2118.
  • Frangogiannis NG. Cardiac fibrosis: cell biological mechanisms, molecular pathways and therapeutic opportunities. Mol Aspects Med. 2019;65:70–99.
  • Li L, Zhao Q, Kong W. Extracellular matrix remodeling and cardiac fibrosis. Matrix Biol. 2018;68-69:490–506.
  • Zaidi Y, Aguilar EG, Troncoso M, et al. Immune regulation of cardiac fibrosis post myocardial infarction. Cell Signal. 2021;77:109837.
  • Zhang N, Wei WY, Li LL, et al. Therapeutic potential of polyphenols in cardiac fibrosis. Front Pharmacol. 2018;9:122.
  • Qiu Q, Cao J, Wang Y, et al. Time course of the effects of buxin yishen decoction in promoting heart function and inhibiting the progression of renal fibrosis in myocardial infarction caused type 2 cardiorenal syndrome rats. Front Pharmacol. 2019;10:1267.
  • Ozato K, Shin DM, Chang TH, et al. 3rd. TRIM family proteins and their emerging roles in innate immunity. Nat Rev Immunol. 2008;8(11):849–860.
  • Liu J, Zhang C, Wang X, et al. Tumor suppressor p53 cross-talks with TRIM family proteins. Genes Dis. 2021;8(4):463–474.
  • Yu C, Ding Z, Liang H, et al. The roles of TIF1gamma in cancer. Front Oncol. 2019;9:979.
  • Boutanquoi PM, Burgy O, Beltramo G, et al. TRIM33 prevents pulmonary fibrosis by impairing TGF-beta1 signalling. Eur Respir J. 2020;55(6).
  • Richter K, Konzack A, Pihlajaniemi T, et al. Redox-fibrosis: impact of TGFbeta1 on ROS generators, mediators and functional consequences. Redox Biol. 2015;6:344–352.
  • Dimauro I, Antonioni A, Mercatelli N, et al. The role of alphaB-crystallin in skeletal and cardiac muscle tissues. Cell Stress Chaperones. 2018;23(4):491–505.
  • Sun J, Wang Z, Shi H, et al. LncRNA FAF inhibits fibrosis induced by angiotensinogen II via the TGFbeta1-P-Smad2/3 signalling by targeting FGF9 in cardiac fibroblasts. Biochem Biophys Res Commun. 2020;521(3):814–820.
  • Shi J, Sun J, Liu L, et al. P16ink4a overexpression ameliorates cardiac remodeling of mouse following myocardial infarction via CDK4/pRb pathway. Biochem Biophys Res Commun. 2022;595:62–68.
  • Valiente-Alandi I, Potter SJ, Salvador AM, et al. inhibiting fibronectin attenuates fibrosis and improves cardiac function in a model of heart failure. Circulation. 2018;138(12):1236–1252.
  • Ramanujam D, Schon AP, Beck C, et al. MicroRNA-21-dependent macrophage-to-fibroblast signaling determines the cardiac response to pressure overload. Circulation. 2021;143(15):1513–1525.
  • Liu W, Zhang D, Li X, et al. TGF-beta1 facilitates cell-cell communication in osteocytes via connexin43- and pannexin1-dependent gap junctions. Cell Death Discov. 2019;5(1):141.
  • Shyu KG, Wang BW, Wu GJ, et al. Mechanical stretch via transforming growth factor-beta1 activates microRNA208a to regulate endoglin expression in cultured rat cardiac myoblasts. Eur J Heart Fail. 2013;15(1):36–45.
  • Xia X, Zuo F, Luo M, et al. Role of TRIM33 in Wnt signaling during mesendoderm differentiation. Sci China Life Sci. 2017;60(10):1142–1149.
  • Zou DB, Mou Z, Wu W, et al. TRIM33 protects osteoblasts from oxidative stress-induced apoptosis in osteoporosis by inhibiting FOXO3a ubiquitylation and degradation. Aging Cell. 2021;20(7):e13367.
  • Gonzalez A, Schelbert EB, Diez J, et al. Myocardial interstitial fibrosis in heart failure: biological and translational perspectives. J Am Coll Cardiol. 2018;71(15):1696–1706.
  • Suetomi T, Willeford A, Brand CS, et al. NLRP3 inflammasome activation initiated in response to pressure overload by Ca(2+)/calmodulin-dependent protein kinase II delta Signaling in cardiomyocytes are essential for adverse cardiac remodeling. Circulation. 2018;138(22):2530–2544.
  • Zhang QJ, He Y, Li Y, et al. Matricellular protein cilp1 promotes myocardial fibrosis in response to myocardial infarction. Circ Res. 2021;129(11):1021–1035.
  • Xu Y, Wu G, Zhang J, et al. TRIM33 overexpression inhibits the progression of clear cell renal cell carcinoma in vivo and in vitro. Biomed Res Int. 2020;2020:8409239.
  • Rajderkar S, Panaretos C, Kaartinen V. Trim33 regulates early maturation of mouse embryoid bodies in vitro. Biochem Biophys Rep. 2017;12:185–192.
  • Weng L, Mitoma H, Trichot C, et al. The E3 ubiquitin ligase tripartite motif 33 is essential for cytosolic RNA-induced NLRP3 inflammasome activation. J Immunol. 2014;193(7):3676–3682.
  • Xie Q, Yao Q, Hu T, et al. High-mobility group A1 promotes cardiac fibrosis by upregulating FOXO1 in fibroblasts. Front Cell Dev Biol. 2021;9:666422.
  • Acunzo J, Katsogiannou M, Rocchi P. Small heat shock proteins HSP27 (HspB1), alphaB-crystallin (HspB5) and HSP22 (HspB8) as regulators of cell death. Int J Biochem Cell Biol. 2012;44(10):1622–1631.
  • Chebotareva NA, Roman SG, Borzova VA, et al. Chaperone-like activity of HSPB5: the effects of quaternary structure dynamics and crowding. Int J Mol Sci. 2020;21(14).